Press release
Acne Market Predicted to See Upsurge Through 2032, Highlights DelveInsight | Clinuvel Pharma, Novan, Dermata Therapeutics, ioPharmX, Bausch Health Americas, Inc., Kintor Pharma, Sol-Gel Technologies, Ltd., Ascletis Pharma, Galderma R&D, Torrent Pharma
To Know in detail about the Acne market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acne Market Forecast
https://www.delveinsight.com/sample-request/acne-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Acne Market Report:
• The Acne market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In December 2024, Dermata Therapeutics, Inc. (NASDAQ: DRMA, DRMAW), a late-stage biotechnology company specializing in medical and aesthetic skin conditions, has announced the successful completion of patient enrollment in its pivotal Phase 3 Spongilla Treatment for Acne Research (STAR-1) study for DMT310. This once-weekly topical treatment is being developed for moderate-to-severe acne. STAR-1 is the first of two Phase 3 trials, and if results are positive, they will support Dermata's submission of a New Drug Application (NDA) for DMT310.
• Key Acne Companies: BioPharmX, Bausch Health Americas, Inc., Kintor Pharma, Sol-Gel Technologies, Ltd., Ascletis Pharma, Galderma R&D, Torrent Pharma, Dermata Therapeutics, Clinuvel Pharma, Novan, Inc., Dermata Therapeutics, Accelovance, Balmoral Medical, Vyne Therapeutics Inc., XOMA (US) LLC, Braintree Laboratories, Teva Pharma, AnaptysBio, Inc., Janssen Research, Cutia Therapeutics, Bausch Health, and others
• Key Acne Therapies: BPX-01, IDP-120, GT20029, KX-826, S6G5T-3, ASC40, GK530G, Dapsone, DMT310, CD5789 (trifarotene), Afamelanotide, NVN1000, Hydrogen Peroxide, Trifarotene Cream, S6G5T-3, GDC 268 Lotion, Isotretinoin, gevokizumab, BLI1100, AKLIEF®, Imsidolimab, RA-18C3, FMX101, IDP-126, and others
• The Acne epidemiology based on gender analyzed that females are predominantly affected compared to males
• The Acne market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Acne pipeline products will significantly revolutionize the Acne market dynamics.
Acne Overview
Acne is a common skin condition that occurs when hair follicles become clogged with oil (sebum), dead skin cells, and bacteria. It typically appears as pimples, blackheads, whiteheads, nodules, or cysts, mainly on the face, chest, back, and shoulders.
Acne is often linked to hormonal changes, genetics, stress, diet, and certain medications. While it is most common during adolescence, it can also affect adults. Treatment options include topical creams, oral medications, lifestyle changes, and professional procedures like laser therapy or chemical peels.
Get a Free sample for the Acne Market Report:
https://www.delveinsight.com/report-store/acne-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Acne Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Acne Epidemiology Segmentation:
The Acne market report proffers epidemiological analysis for the study period 2024-2034 in the 7MM segmented into:
• Total Prevalence of Acne
• Prevalent Cases of Acne by severity
• Gender-specific Prevalence of Acne
• Diagnosed Cases of Episodic and Chronic Acne
Download the report to understand which factors are driving Acne epidemiology trends @ Acne Epidemiology Forecast
https://www.delveinsight.com/sample-request/acne-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Acne Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Acne market or expected to get launched during the study period. The analysis covers Acne market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Acne Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Acne Therapies and Key Companies
• BPX-01: BioPharmX
• IDP-120: Bausch Health Americas, Inc.
• GT20029: Kintor Pharma
• KX-826: KintorPharma
• S6G5T-3: Sol-Gel Technologies, Ltd.
• ASC40: Ascletis Pharma
• GK530G: Galderma R&D
• Dapsone: Torrent Pharma
• DMT310: Dermata Therapeutics
• CD5789 (trifarotene): Galderma R&D
• Afamelanotide: Clinuvel Pharma
• NVN1000: Novan, Inc.
• Hydrogen Peroxide: Dermata Therapeutics
• Trifarotene Cream: Galderma R&D
• S6G5T-3: Accelovance
• GDC 268 Lotion: Balmoral Medical
• Isotretinoin: Vyne Therapeutics Inc.
• gevokizumab: XOMA (US) LLC
• BLI1100: Braintree Laboratories
• AKLIEF®: Teva Pharma
• Imsidolimab: AnaptysBio, Inc.
• RA-18C3: Janssen Research
• FMX101: Cutia Therapeutics
• IDP-126: Bausch Health
Discover more about therapies set to grab major Acne market share @ Acne Treatment Market
https://www.delveinsight.com/sample-request/acne-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Scope of the Acne Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Acne Companies: BioPharmX, Bausch Health Americas, Inc., Kintor Pharma, Sol-Gel Technologies, Ltd., Ascletis Pharma, Galderma R&D, Torrent Pharma, Dermata Therapeutics, Clinuvel Pharma, Novan, Inc., Dermata Therapeutics, Accelovance, Balmoral Medical, Vyne Therapeutics Inc., XOMA (US) LLC, Braintree Laboratories, Teva Pharma, AnaptysBio, Inc., Janssen Research, Cutia Therapeutics, Bausch Health, and others
• Key Acne Therapies: BPX-01, IDP-120, GT20029, KX-826, S6G5T-3, ASC40, GK530G, Dapsone, DMT310, CD5789 (trifarotene), Afamelanotide, NVN1000, Hydrogen Peroxide, Trifarotene Cream, S6G5T-3, GDC 268 Lotion, Isotretinoin, gevokizumab, BLI1100, AKLIEF®, Imsidolimab, RA-18C3, FMX101, IDP-126, and others
• Acne Therapeutic Assessment: Acne current marketed and Acne emerging therapies
• Acne Market Dynamics: Acne market drivers and Acne market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Acne Unmet Needs, KOL's views, Analyst's views, Acne Market Access and Reimbursement
To know more about Acne companies working in the treatment market, visit @ Acne Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/acne-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Acne Market Report Introduction
2. Executive Summary for Acne
3. SWOT analysis of Acne
4. Acne Patient Share (%) Overview at a Glance
5. Acne Market Overview at a Glance
6. Acne Disease Background and Overview
7. Acne Epidemiology and Patient Population
8. Country-Specific Patient Population of Acne
9. Acne Current Treatment and Medical Practices
10. Acne Unmet Needs
11. Acne Emerging Therapies
12. Acne Market Outlook
13. Country-Wise Acne Market Analysis (2019-2032)
14. Acne Market Access and Reimbursement of Therapies
15. Acne Market Drivers
16. Acne Market Barriers
17. Acne Appendix
18. Acne Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Acne Pipeline https://www.delveinsight.com/report-store/acne-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Acne Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Acne market. A detailed picture of the Acne pipeline landscape is provided, which includes the disease overview and Acne treatment guidelines.
Acne Epidemiology https://www.delveinsight.com/report-store/acne-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Acne Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Acne epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports Offered By DelveInsight:
• Sinusitis Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-with-nasal-polyps-market
• Pd-1 & Pdl1 Market: https://www.delveinsight.com/report-store/pd-1-and-pd-l1-inhibitors-competitive-landscape
• Cervical Dysplasia Market: https://www.delveinsight.com/report-store/cervical-dysplasia-market-insights
• Hypogonadism Market: https://www.delveinsight.com/report-store/hypogonadism-market
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Non-hodgkin's Lymphoma Market: https://www.delveinsight.com/report-store/non-hodgkins-lymphoma-market
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acne Market Predicted to See Upsurge Through 2032, Highlights DelveInsight | Clinuvel Pharma, Novan, Dermata Therapeutics, ioPharmX, Bausch Health Americas, Inc., Kintor Pharma, Sol-Gel Technologies, Ltd., Ascletis Pharma, Galderma R&D, Torrent Pharma here
News-ID: 3895271 • Views: …
More Releases from DelveInsight Business Research
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals.
Objective of the Case Study
The…
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics.
According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than…
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies.
Biopsy devices play a crucial role in disease diagnosis by…
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide.
DelveInsight's General Surgery Devices Market Report 2032 provides…
More Releases for Acne
Expanding Acne Rates Support Global Anti-Acne Dermal Patch Market Expansion
As per a new market research report launched by Inkwood Research, the Global Anti-Acne Dermal Patch Market is expected to reach $971.37 million by 2032, projecting a CAGR of 7.32% during the forecast period, 2023-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/anti-acne-dermal-patch-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the…
Expanding Acne Rates Support Global Anti-Acne Dermal Patch Market Expansion
As per a new market research report launched by Inkwood Research, the Global Anti-Acne Dermal Patch Market is expected to reach $971.37 million by 2032, projecting a CAGR of 7.32% during 2023-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/anti-acne-dermal-patch-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive…
Growing Acne Incidences Benefiting Global Anti-Acne Dermal Patch Market Developm …
As per a new market research report launched by Inkwood Research, the Global Anti-Acne Dermal Patch Market is expected to reach $971.37 million by 2032, projecting a CAGR of 7.32% during 2023-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/anti-acne-dermal-patch-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive…
Expanding Acne Rates Support Global Anti-Acne Dermal Patch Market Expansion
As per a new market research report launched by Inkwood Research, the Global Anti-Acne Dermal Patch Market is expected to reach $971.37 million by 2032, projecting a CAGR of 7.32% during 2023-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/anti-acne-dermal-patch-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of…
Rising Cases of Acne Boosting Professional Acne Treatment Market Growth
Factor such as the rising cases of acne, surging adoption of acne treatments, growing healthcare spending, increasing disposable income, sedentary lifestyle, strong product pipeline, and mounting number of research programs are expected to propel the professional acne treatment market at a CAGR of 7.6% during 2020–2030. According to P&S Intelligence, the market size is expected to reach $13,124.5 million by 2030 from $6,298.9 million in 2020. Moreover, the market is…
Global Market Study on Acne Treatment Inflammatory Acne Segment Anticipated.
The global acne treatment market is stagnant in terms of incremental innovation as most players are investing in product reformulation instead of new product development. The analysts of Persistence Market Research have come up with a new publication titled “Acne Treatment Market: Global Industry Analysis and Forecast, 2017 – 2025,” and have observed that the North America region is expected to witness significant growth in market revenue due to rising affinity…
